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Matrix-Assisted Laser Desorption⁄Ionisation Time-Of-Flight Intact Cell Mass Spectrometry 
(MALDI-TOF ICMS) analyses the chemical cellular composition of microorganisms providing 
rapid, discriminatory fingerprints for identification and subtyping of important nosocomial 
pathogens. The remarkable reproducibility of this technique is based on the measurement of 
constantly expressed and highly abundant proteins. The usually observable molecular mass 
range is between 2,000 and 20,000 Da, where important ribosomal proteins appear, which is 
an advantage because these can be easily used as biomarkers. The Burkholderia cepacia 
complex (Bcc) comprises at least 17 closely related bacterial species that have very high 
metabolic versatility, are ubiquitous in the environment and can cause opportunistic 
infections, in particular in patients with cystic fibrosis (CF). Chronic respiratory infections 
caused by these bacteria are, in general, characterised by low responsiveness to antibiotic 
therapy and rapid reduction of lung function. Epidemiological surveys of Bcc bacteria 
involved in respiratory infections among the Portuguese CF population under surveillance at 
this Pediatric and Adult CF Treatment Center of Santa Maria Hospital (HSM), in Lisbon, have 
been carried out by the IST laboratory, covering isolates obtained since 1995. They belong to 
B. cenocepacia (recA lineages IIIA and IIIB), B. cepacia, B. multivorans and B. stabilis 
species, with an exceptionally high representation of B. cepacia. These isolates were 
classified at the species level by established molecular methods, and differentiated at the 
strain level, based on their ribopattern/multilocus sequence typing (MLST) profiles. However, 
these techniques are time-consuming and expensive. In order to overcome these limitations 
MALDI-TOF ICMS was successfully explored as a rapid, precise, and cost-effective tool for 
identification and subtyping of intact Bcc bacteria. The method was tested using isolates 
obtained in the HSM CF Center, including clonal variants retrieved from the same CF 
patients during several years of chronic colonisation, previously characterized by 
conventional molecular biology techniques. 
